{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:12:18Z","timestamp":1791299538224,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T00:00:00Z","timestamp":1399334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/nrrheum.2014.62","type":"journal-article","created":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T12:14:40Z","timestamp":1399378480000},"page":"429-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["G protein-coupled receptors in rheumatology"],"prefix":"10.1038","volume":"10","author":[{"given":"Elena","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Khawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,6]]},"reference":[{"key":"BFnrrheum201462_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrm908","volume":"3","author":"KL Pierce","year":"2002","unstructured":"Pierce, K. L., Premont, R. T. & Lefkowitz, R. J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639\u2013650 (2002).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnrrheum201462_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature11896","volume":"494","author":"AJ Venkatakrishnan","year":"2013","unstructured":"Venkatakrishnan, A. J. et al. Molecular signatures of G-protein-coupled receptors. Nature 494, 185\u2013194 (2013).","journal-title":"Nature"},{"key":"BFnrrheum201462_CR3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4161\/mabs.2.6.13420","volume":"2","author":"CJ Hutchings","year":"2010","unstructured":"Hutchings, C. J., Koglin, M. & Marshall, F. H. Therapeutic antibodies directed at G protein-coupled receptors. MAbs 2, 594\u2013606 (2010).","journal-title":"MAbs"},{"key":"BFnrrheum201462_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.289.5480.739","volume":"289","author":"K Palczewski","year":"2000","unstructured":"Palczewski, K. et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739\u2013745 (2000).","journal-title":"Science"},{"key":"BFnrrheum201462_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1126\/science.1150577","volume":"318","author":"V Cherezov","year":"2007","unstructured":"Cherezov, V. et al. High-resolution crystal structure of an engineered human \u03b22-adrenergic G protein-coupled receptor. Science 318, 1258\u20131265 (2007).","journal-title":"Science"},{"key":"BFnrrheum201462_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev-pharmtox-032112-135923","volume":"53","author":"V Katritch","year":"2013","unstructured":"Katritch, V., Cherezov, V. & Stevens, R. C. Structure-function of the G protein-coupled receptor superfamily. Annu. Rev. Pharmacol. Toxicol. 53, 531\u2013556 (2013).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFnrrheum201462_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.tips.2011.09.003","volume":"33","author":"V Katritch","year":"2012","unstructured":"Katritch, V., Cherezov, V. & Stevens, R. C. Diversity and modularity of G protein-coupled receptor structures. Trends Pharmacol. Sci. 33, 17\u201327 (2012).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnrrheum201462_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.sbi.2011.06.011","volume":"21","author":"J Steyaert","year":"2011","unstructured":"Steyaert, J. & Kobilka, B. K. Nanobody stabilization of G protein-coupled receptor conformational states. Curr. Opin. Struct. Biol. 21, 567\u2013572 (2011).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BFnrrheum201462_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.18388\/abp.2012_2086","volume":"59","author":"D Latek","year":"2012","unstructured":"Latek, D., Modzelewska, A., Trzaskowski, B., Palczewski, K. & Filipek, S. G protein-coupled receptors\u2014recent advances. Acta Biochim. Pol. 59, 515\u2013529 (2012).","journal-title":"Acta Biochim. Pol."},{"key":"BFnrrheum201462_CR10","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.1074\/jbc.M111.311712","volume":"287","author":"PM Giguere","year":"2012","unstructured":"Giguere, P. M., Laroche, G., Oestreich, E. A. & Siderovski, D. P. G-protein signaling modulator-3 regulates heterotrimeric G-protein dynamics through dual association with G\u03b2 and G\u03b1i protein subunits. J. Biol. Chem. 287, 4863\u20134874 (2012).","journal-title":"J. Biol. Chem."},{"key":"BFnrrheum201462_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","volume":"85","author":"N Wettschureck","year":"2005","unstructured":"Wettschureck, N. & Offermanns, S. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85, 1159\u20131204 (2005).","journal-title":"Physiol. Rev."},{"key":"BFnrrheum201462_CR12","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.2337\/db09-1719","volume":"59","author":"A Zhao","year":"2010","unstructured":"Zhao, A. et al. G\u03b1o represses insulin secretion by reducing vesicular docking in pancreatic \u03b2-cells. Diabetes 59, 2522\u20132529 (2010).","journal-title":"Diabetes"},{"key":"BFnrrheum201462_CR13","doi-asserted-by":"publisher","first-page":"e23361","DOI":"10.1371\/journal.pone.0023361","volume":"6","author":"SR Choudhury","year":"2011","unstructured":"Choudhury, S. R., Bisht, N. C., Thompson, R., Todorov, O. & Pandey, S. Conventional and novel G\u03b3 protein families constitute the heterotrimeric G-protein signaling network in soybean. PLoS One 6, e23361 (2011).","journal-title":"PLoS One"},{"key":"BFnrrheum201462_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nature12120","volume":"497","author":"AK Shukla","year":"2013","unstructured":"Shukla, A. K. et al. Structure of active \u03b2-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide. Nature 497, 137\u2013141 (2013).","journal-title":"Nature"},{"key":"BFnrrheum201462_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1096\/fasebj.13.6.715","volume":"13","author":"MS Lombardi","year":"1999","unstructured":"Lombardi, M. S. et al. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J. 13, 715\u2013725 (1999).","journal-title":"FASEB J."},{"key":"BFnrrheum201462_CR16","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.4049\/jimmunol.166.3.1635","volume":"166","author":"MS Lombardi","year":"2001","unstructured":"Lombardi, M. S. et al. Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J. Immunol. 166, 1635\u20131640 (2001).","journal-title":"J. Immunol."},{"key":"BFnrrheum201462_CR17","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1002\/art.27616","volume":"62","author":"KW Frommer","year":"2010","unstructured":"Frommer, K. W. et al. Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis. Arthritis Rheum. 62, 2886\u20132899 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201462_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/13813450802181039","volume":"114","author":"P Penela","year":"2008","unstructured":"Penela, P. et al. G protein-coupled receptor kinase 2 (GRK2) in migration and inflammation. Arch. Physiol. Biochem. 114, 195\u2013200 (2008).","journal-title":"Arch. Physiol. Biochem."},{"key":"BFnrrheum201462_CR19","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/414916a","volume":"414","author":"A Ohta","year":"2001","unstructured":"Ohta, A. & Sitkovsky, M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916\u2013920 (2001).","journal-title":"Nature"},{"issue":"Suppl. 2","key":"BFnrrheum201462_CR20","doi-asserted-by":"crossref","first-page":"ii22","DOI":"10.1136\/ard.62.suppl_2.ii22","volume":"62","author":"JF Kinsel","year":"2003","unstructured":"Kinsel, J. F. & Sitkovsky, M. V. Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands. Ann. Rheum. Dis. 62 (Suppl. 2), ii22\u2013ii24 (2003).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201462_CR21","doi-asserted-by":"publisher","unstructured":"Suarez-Almazor, M. E., Belseck, E., Shea, B., Wells, G. & Tugwell, P. Methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews 1998, Issue 2. Art. No.: CD000957. http:\/\/dx.doi.org\/10.1002\/14651858.CD000957 .","DOI":"10.1002\/14651858.CD000957"},{"key":"BFnrrheum201462_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/rheumatology\/kem279","volume":"47","author":"JA Wessels","year":"2008","unstructured":"Wessels, J. A., Huizinga, T. W. & Guchelaar, H. J. Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford) 47, 249\u2013255 (2008).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrrheum201462_CR23","first-page":"168","volume":"65","author":"H Tian","year":"2007","unstructured":"Tian, H. & Cronstein, B. N. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull. NYU Hosp. Jt Dis. 65, 168\u2013173 (2007).","journal-title":"Bull. NYU Hosp. Jt Dis."},{"key":"BFnrrheum201462_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/art.10712","volume":"48","author":"MC Montesinos","year":"2003","unstructured":"Montesinos, M. C. et al. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum. 48, 240\u2013247 (2003).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201462_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11302-012-9294-7","volume":"8","author":"KA Jacobson","year":"2012","unstructured":"Jacobson, K. A., Balasubramanian, R., Deflorian, F. & Gao, Z. G. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions. Purinergic Signal. 8, 419\u2013436 (2012).","journal-title":"Purinergic Signal."},{"key":"BFnrrheum201462_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1468-3083.2011.04078.x","volume":"26","author":"M David","year":"2012","unstructured":"David, M. et al. Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial. J. Eur. Acad. Dermatol. Venereol. 26, 361\u2013367 (2012).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"BFnrrheum201462_CR27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0031-6997(24)01439-X","volume":"52","author":"PM Murphy","year":"2000","unstructured":"Murphy, P. M. et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52, 145\u2013176 (2000).","journal-title":"Pharmacol. Rev."},{"key":"BFnrrheum201462_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2741\/s53","volume":"2","author":"Z Szekanecz","year":"2010","unstructured":"Szekanecz, Z., Vegvari, A., Szabo, Z. & Koch, A. E. Chemokines and chemokine receptors in arthritis. Front. Biosci. (Schol. Ed.) 2, 153\u2013167 (2010).","journal-title":"Front. Biosci. (Schol. Ed.)"},{"key":"BFnrrheum201462_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2010.07.004","volume":"16","author":"E Neumann","year":"2010","unstructured":"Neumann, E., Lefevre, S., Zimmermann, B., Gay, S. & M\u00fcller-Ladner, U. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol. Med. 16, 458\u2013468 (2010).","journal-title":"Trends Mol. Med."},{"key":"BFnrrheum201462_CR30","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1096\/fj.09-134643","volume":"23","author":"G O'Boyle","year":"2009","unstructured":"O'Boyle, G., Mellor, P., Kirby, J. A. & Ali, S. Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12. FASEB J. 23, 3906\u20133916 (2009).","journal-title":"FASEB J."},{"key":"BFnrrheum201462_CR31","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.4049\/jimmunol.173.9.5776","volume":"173","author":"Z Johnson","year":"2004","unstructured":"Johnson, Z. et al. Interference with heparin binding and oligomerization creates a novel anti-inflammatory strategy targeting the chemokine system. J. Immunol. 173, 5776\u20135785 (2004).","journal-title":"J. Immunol."},{"key":"BFnrrheum201462_CR32","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.4049\/jimmunol.175.2.1257","volume":"175","author":"S Ali","year":"2005","unstructured":"Ali, S. et al. A non-glycosaminoglycan-binding variant of CC chemokine ligand 7 (monocyte chemoattractant protein-3) antagonizes chemokine-mediated inflammation. J. Immunol. 175, 1257\u20131266 (2005).","journal-title":"J. Immunol."},{"key":"BFnrrheum201462_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/glycob\/cwf069","volume":"12","author":"S Ali","year":"2002","unstructured":"Ali, S., Fritchley, S. J., Chaffey, B. T. & Kirby, J. A. Contribution of the putative heparan sulfate-binding motif BBXB of RANTES to transendothelial migration. Glycobiology 12, 535\u2013543 (2002).","journal-title":"Glycobiology"},{"key":"BFnrrheum201462_CR34","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/art.34330","volume":"64","author":"M Yellin","year":"2012","unstructured":"Yellin, M. et al. A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 64, 1730\u20131739 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201462_CR35","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0014-5793(02)03143-5","volume":"527","author":"S Hatse","year":"2002","unstructured":"Hatse, S., Princen, K., Bridger, G., De Clercq, E. & Schols, D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett. 527, 255\u2013262 (2002).","journal-title":"FEBS Lett."},{"key":"BFnrrheum201462_CR36","doi-asserted-by":"publisher","first-page":"3866","DOI":"10.1002\/art.20615","volume":"50","author":"R Garcia-Vicuna","year":"2004","unstructured":"Garcia-Vicuna, R. et al. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum. 50, 3866\u20133877 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201462_CR37","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/jcb.23043","volume":"112","author":"HT Chen","year":"2011","unstructured":"Chen, H. T. et al. Stromal cell-derived factor-1\/CXCR4 promotes IL-6 production in human synovial fibroblasts. J. Cell. Biochem. 112, 1219\u20131227 (2011).","journal-title":"J. Cell. Biochem."},{"key":"BFnrrheum201462_CR38","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.4049\/jimmunol.167.8.4686","volume":"167","author":"P Matthys","year":"2001","unstructured":"Matthys, P. et al. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-\u03b3 receptor-deficient mice. J. Immunol. 167, 4686\u20134692 (2001).","journal-title":"J. Immunol."},{"key":"BFnrrheum201462_CR39","first-page":"652","volume":"26","author":"Y Li","year":"2012","unstructured":"Li, Y. et al. Influence on matrix metalloproteinases 3, 9, and 13 levels after blocking stromal cell derived factor 1\/chemokine receptor 4 signaling pathway with AMD3100 [Chinese]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 26, 652\u2013656 (2012).","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi"},{"key":"BFnrrheum201462_CR40","doi-asserted-by":"publisher","first-page":"R177","DOI":"10.1186\/ar3930","volume":"14","author":"F Wei","year":"2012","unstructured":"Wei, F. et al. Attenuation of osteoarthritis via blockade of the SDF-1\/CXCR4 signaling pathway. Arthritis Res. Ther. 14, R177 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201462_CR41","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/art.23591","volume":"58","author":"CE Vergunst","year":"2008","unstructured":"Vergunst, C. E. et al. Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum. 58, 1931\u20131939 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201462_CR42","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1186\/ar3685","volume":"14","author":"DL Fleishaker","year":"2012","unstructured":"Fleishaker, D. L. et al. Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial. Arthritis Res. Ther. 14, R11 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum201462_CR43","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.ajpath.2012.06.042","volume":"181","author":"MD Singh","year":"2012","unstructured":"Singh, M. D. et al. Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am. J. Pathol. 181, 1158\u20131164 (2012).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum201462_CR44","first-page":"1039","volume":"175","author":"M Lindberg","year":"2013","unstructured":"Lindberg, M. Use of NSAIDs in rheumatoid arthritis should be limited [Danish]. Ugeskr. Laeger 175, 1039\u20131041 (2013).","journal-title":"Ugeskr. Laeger"},{"key":"BFnrrheum201462_CR45","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.pbb.2011.06.022","volume":"99","author":"SG Kinsey","year":"2011","unstructured":"Kinsey, S. G., Naidu, P. S., Cravatt, B. F., Dudley, D. T. & Lichtman, A. H. Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice. Pharmacol. Biochem. Behav. 99, 718\u2013725 (2011).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"BFnrrheum201462_CR46","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1002\/art.30573","volume":"63","author":"T Laragione","year":"2011","unstructured":"Laragione, T., Brenner, M., Sherry, B. & Gulko, P. S. CXCL10 and its receptor CXCR3 regulate synovial fibroblast invasion in rheumatoid arthritis. Arthritis Rheum. 63, 3274\u20133283 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum201462_CR47","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1423-0127-18-86","volume":"18","author":"PZ Chao","year":"2011","unstructured":"Chao, P. Z., Hsieh, M. S., Cheng, C. W., Lin, Y. F. & Chen, C. H. Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytes. J. Biomed. Sci. 18, 86 (2011).","journal-title":"J. Biomed. Sci."},{"key":"BFnrrheum201462_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cyto.2009.10.005","volume":"49","author":"HA Flytlie","year":"2010","unstructured":"Flytlie, H. A. et al. Expression of MDC\/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Cytokine 49, 24\u201329 (2010).","journal-title":"Cytokine"},{"key":"BFnrrheum201462_CR49","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/j.1476-5381.2009.00511.x","volume":"158","author":"F Bellucci","year":"2009","unstructured":"Bellucci, F. et al. Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts. Br. J. Pharmacol. 158, 1996\u20132004 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrrheum201462_CR50","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1124\/pr.57.1.2","volume":"57","author":"LM Leeb-Lundberg","year":"2005","unstructured":"Leeb-Lundberg, L. M., Marceau, F., Muller-Esterl, W., Pettibone, D. J. & Zuraw, B. L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27\u201377 (2005).","journal-title":"Pharmacol. Rev."},{"key":"BFnrrheum201462_CR51","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/ard.2007.080382","volume":"68","author":"IH Song","year":"2009","unstructured":"Song, I. H. et al. Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI. Ann. Rheum. Dis. 68, 75\u201383 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201462_CR52","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00210-012-0762-y","volume":"385","author":"S Meini","year":"2012","unstructured":"Meini, S. et al. Fasitibant prevents the bradykinin and interleukin 1\u03b2 synergism on prostaglandin E2 release and cyclooxygenase 2 expression in human fibroblast-like synoviocytes. Naunyn Schmiedebergs Arch. Pharmacol. 385, 777\u2013786 (2012).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"BFnrrheum201462_CR53","first-page":"73","volume":"4","author":"JV Sarma","year":"2012","unstructured":"Sarma, J. V. & Ward, P. A. New developments in C5a receptor signaling. Cell Health Cytoskelet. 4, 73\u201382 (2012).","journal-title":"Cell Health Cytoskelet."},{"key":"BFnrrheum201462_CR54","unstructured":"Fairlie, D. & Sheils, I. A. Treatment of osteoarthritis: EP 1575606 A1 [online] , (2005)."},{"key":"BFnrrheum201462_CR55","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1146\/annurev-biochem-062411-130916","volume":"82","author":"H Rosen","year":"2013","unstructured":"Rosen, H., Stevens, R. C., Hanson, M., Roberts, E. & Oldstone, M. B. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. Annu. Rev. Biochem. 82, 637\u2013662 (2013).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnrrheum201462_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clim.2010.03.428","volume":"136","author":"S Tsunemi","year":"2010","unstructured":"Tsunemi, S. et al. Effects of the novel immunosuppressant FTY720 in a murine rheumatoid arthritis model. Clin. Immunol. 136, 197\u2013204 (2010).","journal-title":"Clin. Immunol."},{"key":"BFnrrheum201462_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/978-3-7091-1368-4_13","volume":"215","author":"DM Zu Heringdorf","year":"2013","unstructured":"Zu Heringdorf, D. M., Ihlefeld, K. & Pfeilschifter, J. Pharmacology of the sphingosine-1-phosphate signalling system. Handb. Exp. Pharmacol. 215, 239\u2013253 (2013).","journal-title":"Handb. Exp. Pharmacol."},{"key":"BFnrrheum201462_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000315108","volume":"26","author":"MH Graler","year":"2010","unstructured":"Graler, M. H. Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions. Cell. Physiol. Biochem. 26, 79\u201386 (2010).","journal-title":"Cell. Physiol. Biochem."},{"key":"BFnrrheum201462_CR59","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1136\/ard.2010.130336","volume":"69","author":"WR Ferrell","year":"2010","unstructured":"Ferrell, W. R., Kelso, E. B., Lockhart, J. C., Plevin, R. & McInnes, I. B. Protease-activated receptor 2: a novel pathogenic pathway in a murine model of osteoarthritis. Ann. Rheum. Dis. 69, 2051\u20132054 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum201462_CR60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1423-0127-18-43","volume":"18","author":"TL Chen","year":"2011","unstructured":"Chen, T. L. et al. Anti-inflammatory mechanisms of the proteinase-activated receptor 2-inhibiting peptide in human synovial cells. J. Biomed. Sci. 18, 43 (2011).","journal-title":"J. Biomed. Sci."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2014.62.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2014.62","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2014.62.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T20:23:15Z","timestamp":1746217395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2014.62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,6]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFnrrheum201462"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2014.62","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,6]]},"assertion":[{"value":"6 May 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}